Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Pinterest Inc (PINS) Price & Performance

Heron Therapeutics IncTrade
Pinterest IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Pinterest Inc — how do they compare? Heron Therapeutics Inc trades at $0.33 (market cap $61.47M), while Pinterest Inc trades at $22.86 (market cap $13.45B). The key difference: Pinterest Inc is far larger — about 218.8× Heron Therapeutics Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.

HRTXPINS
Market Cap
$61.47M$13.45B
Sector
HealthMedia
52-Week High
$1.49$37.95
52-Week Low
$0.32$15.42
Enterprise Value
$168.21M$13.37B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.

The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.

Pinterest Inc

Pinterest (PINS) trades at $24.37, up 2.91% with strong technical momentum as moving averages signal bullish sentiment. The company demonstrates solid fundamental performance with Q2 2026 EPS beating estimates at $0.43 versus $0.36 expected, marking the third consecutive quarterly beat. Revenue growth remains robust at 18% year-over-year, reaching $1.18 billion in Q2 2026, while maintaining a healthy gross profit margin of 79.47%.

The investment outlook appears favorable with 54% analyst buy ratings and a $28.69 consensus price target representing 18% upside potential. However, risks include intense advertising competition from Meta and slowing revenue guidance for Q3 2026. The stock offers value at current levels given strong AI-driven ad growth and record user metrics, though investors should monitor competitive pressures and execution on international expansion.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX

About Pinterest Inc

Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.

Read more on PINS